Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Melanin Concentrating Hormone Receptor 1 - Pipeline Review, H2 2016 - Key Vendors are AstraZeneca, LEO Pharma & Takeda Pharmaceutical - Research and Markets

Research and Markets
Posted on: 26 Oct 16

Research and Markets has announced the addition of the "Melanin Concentrating Hormone Receptor 1 (G Protein Coupled Receptor 24 or MCH 1R or Somatostatin Receptor Like Protein or GPR24 or SLC1 or MCHR1) - Pipeline Review, H2 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Melanin Concentrating Hormone Receptor 1, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Melanin Concentrating Hormone Receptor 1 and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned:

  • AstraZeneca Plc
  • Boehringer Ingelheim GmbH
  • LEO Pharma A/S
  • Takeda Pharmaceutical Company Limited

Key Topics Covered:

  1. Introduction
  2. Melanin Concentrating Hormone Receptor 1 Overview
  3. Therapeutics Development
  4. Pipeline Products for Melanin Concentrating Hormone Receptor 1 - Overview
  5. Pipeline Products for Melanin Concentrating Hormone Receptor 1 - Comparative Analysis
  6. Melanin Concentrating Hormone Receptor 1 - Therapeutics under Development by Companies
  7. Melanin Concentrating Hormone Receptor 1 - Therapeutics under Investigation by Universities/Institutes
  8. Melanin Concentrating Hormone Receptor 1 - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Melanin Concentrating Hormone Receptor 1 - Products under Development by Companies
  13. Melanin Concentrating Hormone Receptor 1 - Products under Investigation by Universities/Institutes
  14. Melanin Concentrating Hormone Receptor 1 - Companies Involved in Therapeutics Development

For more information about this report visit http://www.researchandmarkets.com/research/p7k2b2/melanin

View source version on businesswire.com: http://www.businesswire.com/news/home/20161026006263/en/

Business Wire
www.businesswire.com

Last updated on: 26/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.